Full View

Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges

C He, Y Yang, K Zheng, Y Chen, S Liu… - … in Chronic Disease, 2021 - journals.sagepub.com
Autoimmune liver disease (AILD) is a series of chronic liver diseases with abnormal immune
responses, including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and …
被引用次数：26 相关文章
[HTML] nih.gov

[HTML][HTML] Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges

C He, Y Yang, K Zheng, Y Chen, S Liu, Y Li… - … Advances in Chronic …, 2021 - ncbi.nlm.nih.gov
Autoimmune liver disease (AILD) is a series of chronic liver diseases with abnormal immune
responses, including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and …

Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges.

C He, Y Yang, K Zheng, Y Chen, S Liu, Y Li… - … Advances in Chronic …, 2021 - europepmc.org
Autoimmune liver disease (AILD) is a series of chronic liver diseases with abnormal immune
responses, including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and …

Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges

C He, Y Yang, K Zheng, Y Chen… - … in chronic disease, 2021 - pubmed.ncbi.nlm.nih.gov
Autoimmune liver disease (AILD) is a series of chronic liver diseases with abnormal immune
responses, including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and …